Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage

Thrombosis and Haemostasis

Volumn 100, Issue 4, 2008, Pages 642-647

  Strijbos, Michiel H ^a   Rao, Chandra ^b   Schmitz, Paul I M ^a   Kraan, Jaco ^a   Lamers, Cor H ^a   Sleijfer, Stefan ^a   Terstappen, Leon W M M ^b   Gratama, Jan W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Immunicon Corporation   (United States)

Author keywords

Biomarkers; CEC; Endothelium; Thrombomodulin; Vascular damage

Indexed keywords

BIOLOGICAL MARKER; ENDOGLIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOMAGNETIC SEPARATION; KIDNEY CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOLOGICAL MARKERS; CATECHOLS; CELL COUNT; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INOSITOL; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SEX CHARACTERISTICS; TEMPERATURE; THROMBOMODULIN; VASCULAR DISEASES;

EID: 54949113624     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-02-0122     Document Type: Article

References (37)

1. Folkman J. Tumor angiogenesis: therapeutic implications. New Engl J Med 1971; 285: 1182-1186.
2. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. New Engl J Med 2007; 356: 125-134.
3. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. New Engl J Med 2007; 356: 115-124.
4. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New Engl J Med 2004; 350: 2335-2342.
5. Ellis LM. Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer. Sem Oncol 2006; 33 (5 Suppl 10): S1-7.
6. Curran SD, Muellner AU, Schwartz LH. Imaging response assessment in oncology. Cancer Imag 2006; 6: S126-130.
7. Cao Y, Liu Q. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. Adv Cancer Res 2007; 97: 203-224.
8. di Tomaso E, Capen D, Haskell A, et al. Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers. Cancer Res 2005; 65: 5740-5749.
9. Blann AD, Woywodt A, Bertolini F, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005; 93: 228-235.
10. Woywodt A, Blann AD, Kirsch T, et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost 2006; 4: 671-677.
11. Mancuso P, Burlini A, Pruneri G, et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97: 3658-3661.
12. Duda DG, Cohen KS, Scadden DT, et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2: 805-810.
13. Strijbos MH, Kraan J, den Bakker MA, et al. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B Clin Cytom 2007; 72: 86-93.
14. Rowand JL, Martin G, Doyle GV, et al. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 2007; 71: 105-113.
15. Smirnov DA, Foulk BW, Doyle GV, et al. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Cancer Res 2006; 66: 2918-2922.
16. Hrachovinova I, Cambien B, Hafezi-Moghadam A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nature Med 2003; 9: 1020-1025.
17. McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86: 746-756.
18. Rini BI, Rathmell WK. Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. Clin Cancer Res 2007; 13: 741s-746s.
19. Zoppini G, Targher G, Zamboni C, et al. Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2006; 16: 543-549.
20. Boffa MC, Karmochkine M. Thrombomodulin: an overview and potential implications in vascular disorders. Lupus 1998; 7 (Suppl 2): S120-125.
21. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb'Haemost 1991; 65: 618-623.
22. Kozuka K, Kohriyama T, Nomura E, et al. Endothelial markers and adhesion molecules in acute ischemic stroke--sequential change and differences in stroke subtype. Atherosclerosis 2002; 161: 161-168.
23. Bardin N, George F, Mutin M, et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996; 48: 531-539.
24. Elshal MF, Khan SS, Takahashi Y, et al. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005; 106: 2923-2924.
25. George F, Poncelet P, Laurent JC, et al. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J Immunol Methods 1991; 139: 65-75.
26. Gougos A, St Jacques S, Greaves A, et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 1992; 4: 83-92.
27. Khan SS, Solomon MA, McCoy JP, Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8.
28. Widemann A, Sabatier F, Arnaud L, et al. CD146-based immunomagnetic enrichment followed by multi-parameter flow cytometry: a new approach to count circulating endothelial cells. J Thromb Haemost 2008; prepub online.
29. Alvarez DF, Huang L, King JA, et al. Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. Am J Physiol Lung Cell Mol Physiol 2008; 294: L419-430.
30. Rustom R, Leggat H, Tomura HR, et al. Plasma thrombomodulin in renal disease: effects of renal function and proteinuria. Clin Nephrol 1998; 50: 337-341.
31. Xu GB, Luo LH, Lu XG. Detection of thrombomodulin in both plasma and tissue extracts of cancer patients and its clinical significance. Zhejiang Da Xue Xue Bao Yi Xue Ban 2003; 32: 141-144.
32. Salmaggi A, Eoli M, Frigerio S, et al. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients. Cancer Lett 1999; 146: 169-172.
33. Biguzzi E, Franchi F, Bucciarelli P, et al. Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma. Thromb Res 2007; 120: 289-293.
34. Goessens BM, van der Graaf Y, Olijhoek JK, et al. The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease. J Vasc Surg 2007; 45: 47-54.
35. Tschudi MR, Barton M, Bersinger NA, et al. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 1996; 98: 899-905.
36. Brown KA, Didion SP, Andresen JJ, et al. Effect of aging, MnSOD deficiency, and genetic background on endothelial function. Evidence for MnSOD haploinsufficiency. Arterioscler Thromb Vasc Biol 2007; 27: 1941-1946.
37. Schrage WG, Eisenach JH, Joyner MJ. Ageing reduces nitric-oxide- and prostaglandin-mediated vasodilatation in exercising humans. J Physiol 2007; 579: 227-236.